Class IIReported 2025-10-29
Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only, Bristol-Myers Squibb Company, Princeton, NJ 08543, NDC 0003-7125-11
Recalled by Bristol-Myers Squibb Company
Reason for Recall
Lack of Assurance of Sterility.
Advertisement